- KASL clinical practice guidelines: Management of Hepatitis C
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 1788561
- Clin Mol Hepatol.
- 2014 Jun;20(2):89-136.
- doi: 10.3350/cmh.2014.20.2.89
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Lesionalized Therapy beyond Personalized Therapy in Cancer Management
-
Chung JK, Kim MJ, Youn H
- KMID: 2129621
- J Korean Med Sci.
- 2014 Oct;29(10):1331-1332.
- doi: 10.3346/jkms.2014.29.10.1331
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Imaging-Based Tumor Treatment Response Evaluation: Review of Conventional, New, and Emerging Concepts
-
Kang H, Lee HY, Lee KS, Kim JH
- KMID: 1383849
- Korean J Radiol.
- 2012 Aug;13(4):371-390.
- doi: 10.3348/kjr.2012.13.4.371
Tumor response may be assessed readily by the use of Response Evaluation Criteria in Solid Tumor version 1.1. However, the criteria mainly depend on tumor size changes. These criteria do... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Assessment and Pharmacogenetics in Molecular and Genomic Epidemiology
-
Park SK, Choi JY
- KMID: 1105309
- J Prev Med Public Health.
- 2009 Nov;42(6):371-376.
- doi: 10.3961/jpmph.2009.42.6.371
In this article, we reviewed the literature on risk assessment (RA) models with and without molecular genomic markers and the current utility of the markers in the pharmacogenetic field. Epidemiological... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent trends in the treatment of chronic hepatitis C
-
Jun DW, Tak WY, Bae SH, Lee YJ
- KMID: 1372647
- Korean J Hepatol.
- 2012 Mar;18(1):22-28.
- doi: 10.3350/kjhep.2012.18.1.22
Pegylated interferon and ribavirin combination therapy is accepted as the standard antiviral treatment for chronic hepatitis C regardless of HCV genotype. This combination therapy achieves higher response rates than previous... -
- CITED
-
- Close
- SHARE
-
- Close
- Heterogeneity of Adenosine Triphosphate-Based Chemotherapy Response Assay in Colorectal Cancer - Secondary Publication
-
Huh JW, Park YA, Lee KY, Sohn SK
- KMID: 1103825
- Yonsei Med J.
- 2009 Oct;50(5):697-703.
- doi: 10.3349/ymj.2009.50.5.697
PURPOSE: Adenosine triphosphate-based chemotherapy response assay (ATP-CRA) is a well-documented and validated technology that can individualize chemotherapy for patients with lung, stomach, or breast cancer. This study explored the feasibility... -
- CITED
-
- Close
- SHARE
-
- Close
